InsiderTrades

Form 4 for INSM INSMED Inc

Accepted 2026-03-31 00:00:00 ET · period of report 2026-03-30 · accession 0001870278-26-000010 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2026-03-31 2026-03-30 INSM Smith Michael Alexander CLO M - OptEx $24.78 +19.6K 57.5K +52% +$486.6K
D 2026-03-31 2026-03-30 INSM Smith Michael Alexander CLO S - Sale+OE $150.98 -19.6K 51.9K -27% -$2.96M
DM 2026-03-31 2026-03-30 INSM Smith Michael Alexander CLO M - OptEx $0.00 -19.6K 8,633 -69% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-03-30 M A 13,989 $27.89 71,509 D — —
2 Common Common Stock 2026-03-30 M A 5,649 $17.07 57,520 D — —
3 Common Common Stock 2026-03-30 S D 19,638 $150.98 51,871 D — —
4 Derivative Stock Option (right to buy) 2026-03-30 M D 13,989 $0.00 18,561 D $27.89 · — to 2031-07-08 13,989 Common Stock (F3) The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
5 Derivative Stock Option (right to buy) 2026-03-30 M D 5,649 $0.00 8,633 D $17.07 · — to 2032-05-11 5,649 Common Stock (F2) The options become exercisable based on the following vesting schedule: 25% vest on the first anniversary of the grant date and an additional 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.